Marker Therapeutics (MRKR) Debt/Equity Ratio: History & Chart

Marker Therapeutics, Inc.(MRKR)

Biotechnology · Houston, TX

$1.03-0.03 (-2.83%)

Delayed quote: Oct 6, 2026, 11:17 AM EDT

About Marker Therapeutics, Inc.

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-edge treatments are engineered to address both blood cancers (hematological malignancies) and solid tumor conditions across the United States. A cornerstone of their approach is the proprietary MultiTAA-specific T cell technology. This method involves producing T cells that are not genetically modified but are specifically designed to target tumors. These specialized T cells can identify multiple antigens associated with tumors, allowing them to effectively eliminate cancer cells that express these markers. Marker Therapeutics' MultiTAA-specific T cell therapies encompass patient-derived (autologous) T cells for treating lymphoma and various solid tumors, as well as donor-derived (allogeneic) T cells for acute myeloid leukemia and acute lymphoblastic leukemia. They also provide "off-the-shelf" solutions applicable to a range of diseases. In addition to T cell therapies, the company is advancing peptide-based immunotherapeutic vaccines. This pipeline includes TPIV100/110, developed to combat breast and ovarian cancer cells, and TPIV200, which is currently undergoing Phase 2 clinical trials for the treatment of breast and ovarian cancers. Founded in 1999, Marker Therapeutics maintains its headquarters in Houston, Texas.

Houston, TX

5 employees

www.markertherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Juan F. Vera

View full financials

MRKR Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.00

DEBT TO EQUITY RATIO AVG TTM

0.00

DEBT TO EQUITY RATIO AVG 3Y

0.00

DEBT TO EQUITY RATIO AVG 5Y

0.13

DEBT TO EQUITY RATIO AVG 10Y

0.10

DEBT TO EQUITY RATIO AVG 15Y

0.00

DEBT TO EQUITY RATIO AVG 20Y

-0.09

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

-100.00%

CURRENT VS 10Y AVG

-100.00%

CURRENT VS 15Y AVG

+100.00%

CURRENT VS 20Y AVG

+100.00%

SECTOR MEDIAN · HEALTHCARE

0.13

median of 593 covered companies

CURRENT VS SECTOR MEDIAN

-100.00%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Marker Therapeutics, Inc. (MRKR)	$17.17M	0.00	0.00	0.00	0.13
Lipocine Inc. (LPCN)vs ›	$17.19M	0.00	0.01	0.01	0.07
Cosmos Health Inc. (COSM)vs ›	$17.34M	0.77	0.78	0.55	1.68
PAVmed Inc. (PAVM)vs ›	$16.85M	0.49	0.39	0.39	2.76
Bionano Genomics, Inc. (BNGO)vs ›	$16.81M	0.21	0.47	0.45	0.39
Dyadic International, Inc. (DYAI)vs ›	$16.42M	N/A	3.08	1.54	1.03
BioCardia, Inc. (BCDA)vs ›	$16.27M	0.11	0.86	0.69	0.45
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.75M	6.30	0.13	0.74	0.48
NextCure, Inc. (NXTC)vs ›	$18.67M	0.35	0.12	0.08	0.06
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.73M	0.00	0.01	0.02	0.02

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Marker Therapeutics, Inc. (MRKR)

$17.17M

0.00

0.13

Lipocine Inc. (LPCN)vs ›

$17.19M

0.00

0.01

0.07

Cosmos Health Inc. (COSM)vs ›

$17.34M

0.77

0.78

0.55

1.68

PAVmed Inc. (PAVM)vs ›

$16.85M

0.49

0.39

2.76

Bionano Genomics, Inc. (BNGO)vs ›

$16.81M

0.21

0.47

0.45

0.39

Dyadic International, Inc. (DYAI)vs ›

$16.42M

N/A

3.08

1.54

1.03

BioCardia, Inc. (BCDA)vs ›

$16.27M

0.11

0.86

0.69

0.45

Allarity Therapeutics, Inc. (ALLR)vs ›

$15.75M

6.30

0.13

0.74

0.48

NextCure, Inc. (NXTC)vs ›

$18.67M

0.35

0.12

0.08

0.06

Neuphoria Therapeutics Inc. (NEUP)vs ›

$18.73M

0.00

0.01

0.02

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Marker Therapeutics, Inc. (MRKR)?

The debt to equity ratio for MRKR stock is 0.00.

Is Marker Therapeutics, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.00 is 100% below its 5-year average of 0.13, near the low end of its 5-year range (0.00–0.47).

What is the TTM average debt to equity ratio for Marker Therapeutics, Inc. (MRKR)?

The TTM average debt to equity ratio for MRKR stock is 0.00.

What is the 3Y average debt to equity ratio for Marker Therapeutics, Inc. (MRKR)?

The 3Y average debt to equity ratio for MRKR stock is 0.00.

What is the 5Y average debt to equity ratio for Marker Therapeutics, Inc. (MRKR)?

The 5Y average debt to equity ratio for MRKR stock is 0.13.

What is the 10Y average debt to equity ratio for Marker Therapeutics, Inc. (MRKR)?

The 10Y average debt to equity ratio for MRKR stock is 0.10.

What is the 15Y average debt to equity ratio for Marker Therapeutics, Inc. (MRKR)?

The 15Y average debt to equity ratio for MRKR stock is 0.00.

What is the 20Y average debt to equity ratio for Marker Therapeutics, Inc. (MRKR)?

The 20Y average debt to equity ratio for MRKR stock is -0.09.

DATE	DEBT TO EQUITY RATIO
2026-06-30	0.00
2026-03-31	0.00
2025-12-31	0.00
2025-09-30	0.00
2025-06-30	0.00
2025-03-31	0.00
2024-12-31	0.00
2024-09-30	0.00
2024-06-30	0.00
2024-03-31	0.00
2023-12-31	0.00
2023-09-30	0.00
2023-06-30	0.00
2023-03-31	0.47
2022-12-31	0.39
2022-09-30	0.34
2022-06-30	0.41
2022-03-31	0.33
2021-12-31	0.27
2021-09-30	0.23
2021-06-30	0.19
2021-03-31	0.17
2020-12-31	0.45
2020-09-30	0.40
2020-06-30	0.27
2020-03-31	0.01
2019-12-31	0.01
2019-09-30	0.02
2019-06-30	0.01
2019-03-31	0.02
2018-12-31	0.00
2018-09-30	0.01
2018-06-30	0.00
2018-03-31	0.01
2017-12-31	0.00
2017-09-30	0.00
2017-06-30	0.00
2017-03-31	0.00
2016-12-31	0.00
2016-09-30	0.00
2016-06-30	0.00
2016-03-31	0.00
2015-12-31	0.00
2015-10-30	-0.02
2015-06-30	-0.01
2015-03-31	-0.03
2014-12-31	-0.05
2014-09-30	-0.08
2014-06-30	-0.17
2014-03-31	-0.09
2013-12-31	-0.40
2013-09-30	-0.52
2013-06-30	-0.53
2013-03-31	-0.37
2012-12-31	-0.26
2012-09-30	-0.32
2012-06-30	-0.33
2012-03-31	-0.32
2011-12-31	-0.32
2011-09-30	-0.31
2011-06-30	-0.34
2011-03-31	-0.21
2010-12-31	-0.28
2010-09-30	-0.32
2010-06-30	-0.33
2010-03-31	-0.44
2009-12-31	-0.54
2009-09-30	-0.23
2009-06-30	-0.13
2009-03-31	-0.31
2008-12-31	-0.27
2008-09-30	-0.15
2008-06-30	-0.45
2008-03-31	-0.42
2007-12-31	-0.39
2007-09-30	-0.30
2007-06-30	-0.12
2007-03-31	-0.12
2006-12-31	-0.19
2006-09-30	-0.24
2006-06-30	-0.49
2006-03-31	-0.36
2005-12-31	-0.24
2005-09-30	-0.23
2005-06-30	-0.27
2005-03-31	-0.35
2004-12-31	-0.20
2004-09-30	-0.35
2004-06-30	-0.46
2004-03-31	0.00
2003-12-31	0.00
2003-09-30	0.00
2003-06-30	0.00
2003-03-31	0.00
2002-12-31	0.00
2002-09-30	-0.04

DATE

DEBT TO EQUITY RATIO

2026-06-30

0.00

2026-03-31

0.00

2025-12-31

0.00

2025-09-30

0.00

2025-06-30

0.00

2025-03-31

0.00

2024-12-31

0.00

2024-09-30

0.00

2024-06-30

0.00

2024-03-31

0.00

2023-12-31

0.00

2023-09-30

0.00

2023-06-30

0.00

2023-03-31

0.47

2022-12-31

0.39

2022-09-30

0.34

2022-06-30

0.41

2022-03-31

0.33

2021-12-31

0.27

2021-09-30

0.23

2021-06-30

0.19

2021-03-31

0.17

2020-12-31

0.45

2020-09-30

0.40

2020-06-30

0.27

2020-03-31

0.01

2019-12-31

0.01

2019-09-30

0.02

2019-06-30

0.01

2019-03-31

0.02

2018-12-31

0.00

2018-09-30

0.01

2018-06-30

0.00

2018-03-31

0.01

2017-12-31

0.00

2017-09-30

0.00

2017-06-30

0.00

2017-03-31

0.00

2016-12-31

0.00

2016-09-30

0.00

2016-06-30

0.00

2016-03-31

0.00

2015-12-31

0.00

2015-10-30

-0.02

2015-06-30

-0.01

2015-03-31

-0.03

2014-12-31

-0.05

2014-09-30

-0.08

2014-06-30

-0.17

2014-03-31

-0.09

2013-12-31

-0.40

2013-09-30

-0.52

2013-06-30

-0.53

2013-03-31

-0.37

2012-12-31

-0.26

2012-09-30

-0.32

2012-06-30

-0.33

2012-03-31

-0.32

2011-12-31

-0.32

2011-09-30

-0.31

2011-06-30

-0.34

2011-03-31

-0.21

2010-12-31

-0.28

2010-09-30

-0.32

2010-06-30

-0.33

2010-03-31

-0.44

2009-12-31

-0.54

2009-09-30

-0.23

2009-06-30

-0.13

2009-03-31

-0.31

2008-12-31

-0.27

2008-09-30

-0.15

2008-06-30

-0.45

2008-03-31

-0.42

2007-12-31

-0.39

2007-09-30

-0.30

2007-06-30

-0.12

2007-03-31

-0.12

2006-12-31

-0.19

2006-09-30

-0.24

2006-06-30

-0.49

2006-03-31

-0.36

2005-12-31

-0.24

2005-09-30

-0.23

2005-06-30

-0.27

2005-03-31

-0.35

2004-12-31

-0.20

2004-09-30

-0.35

2004-06-30

-0.46

2004-03-31

0.00

2003-12-31

0.00

2003-09-30

0.00

2003-06-30

0.00

2003-03-31

0.00

2002-12-31

0.00

2002-09-30

-0.04

Debt to Equity Ratio: 0.00

MRKR Debt to Equity Ratio

MRKR Average Debt to Equity Ratio Chart

MRKR Current vs Average Debt to Equity Ratio Chart

MRKR Debt to Equity Ratio Metrics

MRKR Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

MRKR Debt to Equity Ratio History

Related Metrics